XML 59 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Details Narrative)
$ / shares in Units, ₪ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 18, 2020
USD ($)
Feb. 04, 2020
USD ($)
Apr. 28, 2019
USD ($)
May 25, 2018
USD ($)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
ILS (₪)
Jun. 30, 2012
Dec. 31, 2020
USD ($)
shares
Monthly consultation fee in USD | $ / shares         $ 12.40      
Litigation settlement $ 484,614              
Joseph Mona [Member]                
Settlement amount   $ 151            
CardioSert Ltd [Member]                
Initial payment       $ 250 $ 50      
Number of common shares acquired | shares       6,738        
Number of common shares acquired, value       $ 74        
Buy back amount per patent | $ / shares         $ 1.00      
Alliance Investment Management, Ltd. [Member]                
Litigation settlement     $ 468          
Securities Purchase Agreement [Member]                
Settlement amount               $ 3,700
Number of post-stock split shares returned | shares               83,333
Purchase price of plaintiffs               $ 6,750
Minimum [Member] | CardioSert Ltd [Member]                
Investments         $ 2,000      
Minimum [Member] | Technion Research and Development Foundation Limited [Member]                
Royalties payable as percentage of future sales             1.50%  
Maximum [Member] | Technion Research and Development Foundation Limited [Member]                
Royalties payable as percentage of future sales             3.00%  
NIS [Member]                
Monthly consultation fee | ₪           ₪ 40    
Currency exchange rate, description         Exchange rate of NIS3.215 to the dollar Exchange rate of NIS3.215 to the dollar    
Israeli Innovation Authority [Member] | 2013 Through 2020 [Member]                
Total grants obtained               $ 1,500
Israeli Innovation Authority [Member] | 2013 Through 2020 [Member] | Minimum [Member]                
Royalties payable as percentage of future sales               3.00%
Israeli Innovation Authority [Member] | 2013 Through 2020 [Member] | Maximum [Member]                
Royalties payable as percentage of future sales               3.50%